Evidence map›Paper›PMID 31548561›Full record

ArticleScientific reports2019

A novel Ancestral Beijing sublineage of Mycobacterium tuberculosis suggests the transition site to Modern Beijing sublineages.

Pravech Ajawatanawong, Hideki Yanai, Nat Smittipat, Areeya Disratthakit, Norio Yamada, Reiko Miyahara, Supalert Nedsuwan, Worarat Imasanguan, Pacharee Kantipong, Boonchai Chaiyasirinroje and 16 more

Abstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. A large geno-spatial cluster of multi-drug resistant tuberculosis outbreak in a western district of Thailand.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Whole-genome sequencing ofMicrobiology resource announcements · 2024
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Distribution and origins ofMicrobial genomics · 2023
    Article
  19. Distribution ofTropical medicine and infectious disease · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Pravech AjawatanawongDepartment of Microbiology, Faculty of Science, Mahidol University, Rama 6 Road, Bangkok, Thailand.
Hideki YanaiFukujuji Hospital, Japan Anti-Tuberculosis Association (JATA), Kiyose, Japan.
Nat SmittipatNational Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency, Phahonyothin Road, Pathumthani, Thailand.
Areeya DisratthakitDepartment of Medical Sciences, Ministry of Public Health, Tiwanon Road, Nonthaburi, Thailand.
Norio YamadaResearch Institute of Tuberculosis, JATA, Kiyose, Japan.
Reiko MiyaharaGenome Medical Science Project, National Center for Global Health and Medicine, Tokyo, Japan.
Supalert NedsuwanChiangrai Prachanukroh Hospital, Ministry of Public Health, Chiangrai, Thailand.
Worarat ImasanguanChiangrai Prachanukroh Hospital, Ministry of Public Health, Chiangrai, Thailand.
Pacharee KantipongChiangrai Prachanukroh Hospital, Ministry of Public Health, Chiangrai, Thailand.
Boonchai ChaiyasirinrojeTB-HIV Research Foundation, Chiangrai, Thailand.
Jiraporn WongyaiTB-HIV Research Foundation, Chiangrai, Thailand.
Supada PlitphonganphimDepartment of Biostatistics, Faculty of Public Health, Mahidol University, Bangkok, Thailand.
Pornpen TantivitayakulDepartment of Oral Microbiology, Faculty of Dentistry, Mahidol University, Bangkok, Thailand.
Jody PhelanLondon School of Hygiene and Tropical Medicine, London, UK.ORCID http://orcid.org/0000-0001-8323-7019
Julian ParkhillWelcome Trust Sanger Institute, Hinxton, Cambridge, UK.ORCID http://orcid.org/0000-0002-7069-5958
Taane G ClarkLondon School of Hygiene and Tropical Medicine, London, UK.ORCID http://orcid.org/0000-0001-8985-9265
Martin L HibberdLondon School of Hygiene and Tropical Medicine, London, UK.
Wuthiwat RuangchaiDepartment of Microbiology, Faculty of Science, Mahidol University, Rama 6 Road, Bangkok, Thailand.
Panawun PalittapongarnpimDepartment of Microbiology, Faculty of Science, Mahidol University, Rama 6 Road, Bangkok, Thailand.
Tada JuthayothinNational Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency, Phahonyothin Road, Pathumthani, Thailand.
Yuttapong ThawornwattanaDepartment of Microbiology, Faculty of Science, Mahidol University, Rama 6 Road, Bangkok, Thailand.
Wasna ViratyosinNational Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency, Phahonyothin Road, Pathumthani, Thailand.
Sissades TongsimaNational Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency, Phahonyothin Road, Pathumthani, Thailand.ORCID http://orcid.org/0000-0002-1491-1839
Surakameth MahasirimongkolDepartment of Medical Sciences, Ministry of Public Health, Tiwanon Road, Nonthaburi, Thailand.
Katsushi TokunagaGenome Medical Science Project, National Center for Global Health and Medicine, Tokyo, Japan.
Prasit PalittapongarnpimDepartment of Microbiology, Faculty of Science, Mahidol University, Rama 6 Road, Bangkok, Thailand. Prasit.pal@mahidol.ac.th.

Funding

TB/MDR-TB Research training and Capacity Strengthening for LMIC in Southeast Asia Phase II: Promotion of Diversity, Equity and Inclusion (DEI)D43TW009522 · FIC · PRINCE OF SONGKLA UNIVERSITY · PI Virasakdi Chongsuvivatwong · 2015 to 2026
$3.0M
Biotechnology and Biological Sciences Research Council BB/R013063/1FIC NIH HHS D43 TW009522Medical Research Council MR/M01360X/1Medical Research Council MR/N010469/1Medical Research Council MR/R020973/1Medical Research Council MR/R025576/1Wellcome TrustWellcome Trust WT081814/Z/06/ZWellcome Trust WT088559MAWellcome Trust WT096249/Z/11/BWellcome Trust WT098051
6 · The paper itself

Abstract

Global Mycobacterium tuberculosis population comprises 7 major lineages. The Beijing strains, particularly the ones classified as Modern groups, have been found worldwide, frequently associated with drug resistance, younger ages, outbreaks and appear to be expanding. Here, we report analysis of whole genome sequences of 1170 M. tuberculosis isolates together with their patient profiles. Our samples belonged to Lineage 1-4 (L1-L4) with those of L1 and L2 being equally dominant. Phylogenetic analysis revealed several new or rare sublineages. Differential associations between sublineages of M. tuberculosis and patient profiles, including ages, ethnicity, HIV (human immunodeficiency virus) infection and drug resistance were demonstrated. The Ancestral Beijing strains and some sublineages of L4 were associated with ethnic minorities while L1 was more common in Thais. L2.2.1.Ancestral 4 surprisingly had a mutation that is typical of the Modern Beijing sublineages and was common in Akha and Lahu tribes who have migrated from Southern China in the last century. This may indicate that the evolutionary transition from the Ancestral to Modern Beijing sublineages might be gradual and occur in Southern China, where the presence of multiple ethnic groups might have allowed for the circulations of various co-evolving sublineages which ultimately lead to the emergence of the Modern Beijing strains.

Indexed as

Biological EvolutionPhylogenyAdultAgedBeijingChinaDrug Resistance, Multiple, BacterialFemaleHumansMaleMiddle AgedMycobacterium tuberculosisTuberculosis, Multidrug-ResistantTuberculosis, PulmonaryWhole Genome SequencingYoung Adult

Identifiers

PMID31548561
PMCPMC6757101

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.